Market Overview

Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest Cash

Share:
Related MYL
Deutsche Tweaking Its Mylan View Following CEO's Congressional Testimony
USA Today On EpiPen Saga: Calling It 'Controversial' Is Far From Haphazard
Biotech Forum Daily Digest: Can Biotech Broach Resistance Levels? Worst Now Over For Mylan? Spotlight Feature On Bellicum Pharmaceuticals (Seeking Alpha)
Related SLXP
BMO Still Believes Valeant Is Undervalued
Benzinga's Volume Movers

Below are the top drugs-generic stocks on the NYSE and the NASDAQ in terms of cash.

Salix Pharmaceuticals (NASDAQ: SLXP) had $775.90 million in total cash and $869.10 million in total debt for the latest quarter.

Mylan (NASDAQ: MYL) had $412.67 million in total cash for the latest quarter. However, Mylan had $5.37 billion in total debt for the same period.

Hi Tech Pharmacal Co (NASDAQ: HITK) had $104.09 million in total cash and $1.42 million in total debt for the latest quarter.

Akorn (NASDAQ: AKRX) had $38.40 million in total cash and $103.65 million in total debt for the latest quarter.

Posted-In: Drugs-Generic Industry highest cash NASDAQ StocksTrading Ideas

 

Related Articles (AKRX + HITK)

View Comments and Join the Discussion!